Tag : genome sequencing

Leader in spatially resolved, single-cell transcriptomics appoints Bob Koshgarian as VP of Operations, advancing company towards MERSCOPE™ commercialization Vizgen, the life science company dedicated to...

Brian Stolz Joins as Chief People Officer, Diana King as VP of Customer Support, and Jordan Neysmith as VP of Engineering Element Biosciences, developer of...

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced expansion plans to support...

Financing led by Patient Square Capital with participation from leading life sciences investors to support the further development of Kriya’s core technology platforms, advancement of...

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers,...

First allogeneic CAR-T cell therapy with a PD-1 knockout in clinical studies Initial data from trial expected in 2022 Caribou Biosciences, Inc., a leading clinical-stage CRISPR...

Life Edit, an ElevateBio portfolio company, to collaborate with expert scientific advisors to maximize potential of genome-editing platform including novel RNA-guided nucleases and base editors...

Rob Brainin Named Executive Vice President and Chief Business Officer;Bill Zondler Appointed Senior Vice President and Chief Information Officer Veracyte, Inc. (Nasdaq: VCYT), a global genomic...

– Verge to Receive Up to $25M in Upfront, Equity Investment and Potential Near-Term Payments, with Additional Milestone Value of $694M and Potential Downstream Royalties – Collaboration...

Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for serious genetic diseases,...